Today, the Centers for Disease Control and the Food & Drug Administration have recommended a hiatus in the use of the Johnson & Johnson vaccine, citing new studies that may link the vaccine to increases in blood clots.
Until recently, the Johnson & Johnson Covid-19 vaccine was the vaccine of choice for African American communities, according to several reports.
MTO News learned that healthcare providers viewed J & J’s shot as a blessing as it can be stored at refrigerator temperature for months and only takes one dose – unlike Pfizer and Moderna.
The J&J vaccine has been seen as a vital tool by health care providers to deliver life-saving vaccines to hard-to-reach places that may not be reliably refrigerated, such as tribal areas, poorer neighborhoods, and rural and border communities, officials told CNBC.
“Just because it’s the easiest doesn’t mean it’s the right thing,” Detroit-based Logan Patmon told CNBC.
MUSLIM TIK TOK STAR TROLLS ON HIS WIFE; By marrying her best friend
CNBC claimed the J&J vaccine was being sent by healthcare providers “to poorer zip codes in major cities and rural communities.”
Today the Centers for Disease Control and Prevention and the Food and Drug Administration announced that they are halting the spread of the J&J vaccine. The agencies also recommended that all healthcare providers stop giving the vaccine to patients.
According to federal agencies, they are investigating unusual blood clots in six women that appeared 6 to 13 days after the vaccination.
The clots appeared in veins that drain blood from the brain and occurred along with low platelets. All six cases involved women between the ages of 18 and 48.
According to the agencies, these cases appear to be rare. In the United States, more than 6.8 million doses of the J&J vaccine have been administered, the vast majority with no or minor side effects.
The CDC and FDA continue to recommend Americans continue to receive the Covid vaccine. The agencies remain confident that all other Covid vaccines available are safe.